April 21, 2017 - By Nellie Frank
Analysts expect Radius Health Inc (NASDAQ:RDUS) to report $-1.32 EPS on May, 4.They anticipate $0.38 EPS change or 40.43% from last quarter’s $-0.94 EPS. After having $-1.22 EPS previously, Radius Health Inc’s analysts see 8.20% EPS growth. It closed at $38.11 lastly. It is down 29.96% since September 14, 2016 and is downtrending. It has underperformed by 40.78% the S&P500.
Spring Bank Pharmaceuticals Incorporated (NASDAQ:SBPH) had an increase of 83.18% in short interest. SBPH’s SI was 40,300 shares in April as released by FINRA. Its up 83.18% from 22,000 shares previously. With 21,900 avg volume, 2 days are for Spring Bank Pharmaceuticals Incorporated (NASDAQ:SBPH)’s short sellers to cover SBPH’s short positions. The SI to Spring Bank Pharmaceuticals Incorporated’s float is 0.71%. It closed at $8.94 lastly. It is down 30.48% since September 14, 2016 and is downtrending. It has underperformed by 41.31% the S&P500.
Spring Bank Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The company has market cap of $81.98 million. The Firm is engaged in the discovery and development of a class of therapeutics using its small molecule nucleic acid hybrid chemistry platform. It currently has negative earnings. The Firm is developing its SMNH product, SB 9200, for the treatment of viral diseases.
Investors sentiment decreased to 0.84 in 2016 Q4. Its down 0.60, from 1.44 in 2016Q3. It is negative, as 33 investors sold Radius Health Inc shares while 46 reduced holdings. 17 funds opened positions while 49 raised stakes. 40.48 million shares or 1.31% less from 41.02 million shares in 2016Q3 were reported. 73,100 were accumulated by California Pub Employees Retirement. Hsbc Hldg Public Ltd owns 5,435 shares. Geode Mgmt Lc invested 0% of its portfolio in Radius Health Inc (NASDAQ:RDUS). Blackrock Gru Ltd owns 20,557 shares for 0% of their portfolio. Loring Wolcott Coolidge Fiduciary Advsr Limited Liability Partnership Ma holds 0% in Radius Health Inc (NASDAQ:RDUS) or 10 shares. Sei Investments holds 2,338 shares or 0% of its portfolio. Global X Co Lc owns 127 shares for 0% of their portfolio. Salzhauer Michael reported 7,500 shares or 0.14% of all its holdings. Blackrock invested in 2,675 shares. Marshall Wace Limited Liability Partnership accumulated 156,432 shares. 91,701 were accumulated by Tiaa Cref Inv Ltd Company. Royal Bancshares Of Canada reported 356,663 shares. Oxford Asset Mngmt reported 190,540 shares. Finemark Bancorporation Trust invested in 0% or 343 shares. Guggenheim Capital Ltd Liability owns 65,355 shares for 0.01% of their portfolio.
Radius Health, Inc. is a biopharmaceutical company. The company has market cap of $1.66 billion. The Firm is focused on the developing therapeutics in the areas of osteoporosis, oncology and endocrine diseases. It currently has negative earnings. The Company’s lead investigational product candidate, abaloparatide for subcutaneous injection, or abaloparatide-SC, has completed Phase III development for potential use in the treatment of women with postmenopausal osteoporosis.
- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Nellie Frank